Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Kungliga Tekniska Hoegskolan |
| Country | Sweden |
| Start Date | Jun 01, 2024 |
| End Date | May 31, 2029 |
| Duration | 1,825 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 101116523 |
A well-controlled microenvironment is paramount for reproducible biomolecular studies.
Organs-on-chips are in-vitro cell culture systems that employ microfluidic and biomaterial engineering towards that goal.
They combine the advantages of animal models (physiological environment) with those of plastic-dish culture (human cells), and thereby hold exceptional promise in unraveling the biological processes that underlie health and disease.
Yet control over the biochemical environment remains poor.With CHIPzophrenia, I propose to develop a new generation of organ-chip, one that features feedback-enabled control of the biochemical environment.
I aim to realize dynamic and well-controlled application of stable therapeutics (via feedback sensors and flow control), and crucially also of highly volatile oxygen/nitrogen stressors by relying on electrochemistry to generate them in situ.
My goal is to moreover implement a highly functional modular architecture so that the system can easily be repurposed and sensor/control modules reused – all with negligible dead volumes and displacement (key challenges in current organ-chips towards novel functionalities).I intend to leverage this organ-chip to elucidate how nitrosative stressors disrupt the complex multicellular interactions of the blood-brain barrier, where existing in-vitro models fail to provide the requisite cellular and chemical microenvironment.
Yet such disruption is implicated in a wide array of disorders – including schizophrenia, where our biological understanding remains poor and in-vivo models are uniquely challenging.
I will specifically test the hypothesis that nitrosative dysregulation of perivascular cells plays a causative role in neuronal dysfunction associated with the disorder.
Not only will CHIPzophrenia thus reveal new potential treatment targets, but it will also establish the platform as a transformative tool for dynamic and well-controlled in-vitro research into stress-related disorders and beyond.
Kungliga Tekniska Hoegskolan
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant